Literature DB >> 2878061

Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke.

K Fuxe, K Andersson, A Härfstrand, L F Agnati.   

Abstract

By means of a Walton smoke machine male rats were exposed to cigarette smoke from 1 to 4 cigarettes. Dopamine (DA) levels and utilization in the telencephalon were measured by quantitative histofluorimetry in discrete DA nerve terminal systems of the neostriatum, nucleus accumbens and tuberculum olfactorium. Exposure to unfiltered but not to filtered (Cambridge glass fibre filter) cigarette smoke resulted in a dose-dependent increase in DA utilization in the diffuse types of DA nerve terminal systems in the anterior nucleus accumbens and the lateral posterior tuberculum olfactorium. After exposure to the smoke from 4 cigarettes also an increase in DA utilization was observed in the dotted type (also cholecystokinin [CCK] positive) of DA nerve terminals of the nucleus accumbens (posterior part). The DA utilization in various parts of the neostriatum and in the dotted type of DA nerve terminals in the medial posterior tuberculum olfactorium were unaffected by acute intermittent exposure to cigarette smoke. The DA levels in the various DA nerve terminal systems in neostriatum, nucleus accumbens and tuberculum olfactorium were unaffected with the exception of the dotted and CCK positive type of DA nerve terminals of the nucleus accumbens, where a small reduction of the DA stores was shown following acute intermittent exposure to smoke from 4 cigarettes. The effects induced by exposure to the cigarette smoke in the limbic DA terminals were counteracted by mecamylamine pretreatment. It is suggested that the nicotine component of the cigarette smoke via activation of nicotinic cholinergic receptors can enhance DA release in discrete DA nerve terminal systems of the nucleus accumbens and tuberculum olfactorium. These actions may at least in part mediate the euphoria induced by inhalation of cigarette smoke.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878061     DOI: 10.1007/bf01243356

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  13 in total

1.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.

Authors:  I I Kessler; E L Diamond
Journal:  Am J Epidemiol       Date:  1971-07       Impact factor: 4.897

2.  Inhalation bioassay chemistry--Walton Horizontal Smoking Machine for inhalation exposure of rodents to cigarette smoke.

Authors:  M R Guerin; J R Stokely; C E Higgins; J H Moneyhun; R W Holmberg
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

3.  Smoking and Parkinson's disease.

Authors:  R B Godwin-Austen; P N Lee; M G Marmot; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-07       Impact factor: 10.154

4.  Effects of single injections of nicotine on the ascending dopamine pathways in the rat. Evidence for increases of dopamine turnover in the mesostriatal and mesolimbic dopamine neurons.

Authors:  K Andersson; K Fuxe; L F Agnati
Journal:  Acta Physiol Scand       Date:  1981-07

5.  Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection.

Authors:  M Curvall; E Kazemi-Vala; C R Enzell
Journal:  J Chromatogr       Date:  1982-11-12

6.  Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors.

Authors:  R J Baumann; H D Jameson; H E McKean; D G Haack; L M Weisberg
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

7.  Autoradiographic distribution of nicotine receptors in rat brain.

Authors:  P B Clarke; C B Pert; A Pert
Journal:  Brain Res       Date:  1984-12-10       Impact factor: 3.252

8.  Determinations of catecholamine half-lives and turnover rates in discrete catecholamine nerve terminal systems of the hypothalamus, the preoptic region and the forebrain by quantitative histofluorimetry.

Authors:  K Andersson; K Fuxe; L F Agnati
Journal:  Acta Physiol Scand       Date:  1985-04

9.  Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems.

Authors:  K Andersson; K Fuxe; L F Agnati; P Eneroth
Journal:  Med Biol       Date:  1981-06

10.  Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors:  M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  6 in total

1.  Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine.

Authors:  M E Benwell; D J Balfour; C E Birrell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

2.  Studies on the influence of nicotine infusions on mesolimbic dopamine and locomotor responses to nicotine.

Authors:  M E Benwell; D J Balfour; L F Khadra
Journal:  Clin Investig       Date:  1994-02

Review 3.  Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.

Authors:  G Mudo; N Belluardo; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-08-17       Impact factor: 3.575

4.  Effects of subchronic nicotine administration on central dopaminergic mechanisms in the rat.

Authors:  L A Carr; P P Rowell; W M Pierce
Journal:  Neurochem Res       Date:  1989-06       Impact factor: 3.996

5.  Positron emission tomographic measure of brain dopamine dependence to nicotine as a model of drugs of abuse.

Authors:  Edward F Domino; Hideo Tsukada; Norihiro Harada
Journal:  Psychopharmacology (Berl)       Date:  2009-01-10       Impact factor: 4.530

6.  The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity.

Authors:  M E Benwell; D J Balfour
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.